Fibrocartilaginous lipoma: a clinicopathological analysis of six cases.
10.3760/cma.j.cn112151-20230208-00104
- Author:
H L LI
1
;
J WANG
2
;
H CHENG
3
;
S J ZHANG
4
;
R J MAO
1
Author Information
1. Department of Pathology, Foshan Traditional Chinese Medicine Hospital, Foshan 528000, China.
2. Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
3. Department of Pathology, the Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
4. Department of Pathology, Fourth Affiliated Hospital of Harbin Medical University, Harbin 150001, China.
- Publication Type:Journal Article
- MeSH:
Male;
Female;
Humans;
Adult;
Middle Aged;
Aged;
Desmin/analysis*;
China;
Lipoma/pathology*;
Fibroblasts/pathology*;
S100 Proteins/analysis*;
Diagnosis, Differential;
Fibrocartilage/pathology*;
Biomarkers, Tumor/analysis*
- From:
Chinese Journal of Pathology
2023;52(8):827-831
- CountryChina
- Language:Chinese
-
Abstract:
Objective: To investigate the clinicopathological characteristics, immunophenotype, molecular genetics and differential diagnoses of fibrocartilaginous lipomas which consist of adipose tissue, fibrocartilage and fibrous elements. Methods: The clinicopathological features, immunohistochemical profiles and molecular profiles in six cases of fibrocartilaginous lipomas diagnosed at Foshan Traditional Chinese Medicine Hospital, Fudan University Shanghai Cancer Center, the Fifth Affiliated Hospital of Zhengzhou University and the Fourth Affiliated Hospital of Harbin Medical University from January 2017 to February 2022 were included. The follow-up information, diagnosis and differential diagnoses were evaluated. Results: There were three males and three females with a median age of 53 years (range 36-69 years) at presentation. Tumors were located in the extremities, the head and neck region and trunk; and presented as painless masses that were located in the subcutaneous tissue or deep soft tissue. Grossly, three cases were well defined with thin capsule, one case was well circumscribed without capsule, two cases were surrounded by some skeletal muscle. The tumors were composed of fatty tissue with intermingled gray-white area. The tumors ranged from 1.50-5.50 cm (mean 2.92 cm). Microscopically, the hallmark of these lesions was the complex admixture of mature adipocytes, fibrocartilage and fibrous element in varying proportions; the fibrocartilage arranged in a nodular, sheet pattern with some adipocytes inside. Tumor cells had a bland appearance without mitotic activity. Immunohistochemical analysis using antibodies to SMA, desmin, S-100, SOX9, HMGA2, RB1, CD34, adipopholin was performed in six cases; the fibrocartilage was positive for S-100 and SOX9, adipocytes were positive for S-100, adipopholin and HMGA2; CD34 was expressed in the fibroblastic cells, while desmin and SMA were negative. Loss of nuclear RB1 expression was not observed. Other genetic abnormalities had not been found yet in four cases. Follow-up information was available in six cases; there was no recurrence in five, and one patient only underwent biopsy of the mass. Conclusions: Fibrocartilaginous lipoma is a benign lipomatous tumor with mature adipocytes, fibrocartilage and fibrous elements. By immunohistochemistry, they show the expression of fat and cartilage markers. No specific molecular genetics changes have been identified so far. Familiarity with its clinicopathological features helps the distinction from its morphologic mimics.
